New diabetes clinical trial: Glycemic Variations During the Menstrual Cycle in Women With Type 1 Diabetes

Published on: February 28, 2022 at 10:30PM
Condition:   Type1diabetes
Interventions:   Device: Continuous glucose monitoring;   Drug: Insulin;   Other: Premenstrual symptoms;   Other: Ovulation kits;   Device: Fitbit Inspire 2;   Other: Keenoa;   Other: Menstrual cycle
Sponsor:   Institut de Recherches Cliniques de Montreal
Not yet recruiting
https://ift.tt/57jE8Tv

Comments

Popular posts from this blog